- A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma
Chenicheri Kizhakkeveettil Keerthana et al, 2024, Anti-Cancer Agents in Medicinal Chemistry CrossRef - A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma
Xianqiang Zhou et al, 2024, Current Pharmaceutical Design CrossRef - A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Artemisia annua on the Treatment of Hepatocellular Carcinoma
Shuqiao Zhang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef - Beyond Promoter: The Role of Macrophage in Invasion and Progression of Renal Cell Carcinoma
Haibao Zhang et al, 2020, Current Stem Cell Research & Therapy CrossRef - Study on the mechanism of action of Scutellaria barbata on hepatocellular carcinoma based on network pharmacology and bioinformatics
An-Yin Yang et al, 2023, Frontiers in Pharmacology CrossRef - The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review
Maria Rosaria Paravati et al, 2024, Hepatoma Research CrossRef - Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells
Weijia Zhao et al, 2020, ACS Omega CrossRef - Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology
Ho-Sung Lee et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef - Piperine induces cellular stresses, apoptosis, and cytotoxicity via JNK signaling and has concentration-dependently additive or synergistic effects with sorafenib in hepatocellular carcinoma: an in-vitro study
Gulben Sayilan Ozgun et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef - Network Pharmacology Integrated with Transcriptomics Deciphered the Potential Mechanism of Codonopsis pilosula against Hepatocellular Carcinoma
Zhili Liu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef - Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy
Qian Li et al, 2024, Frontiers in Pharmacology CrossRef - HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma
Shengjie Ye et al, 2024, Cancer Nanotechnology CrossRef